ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,451Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 1456

$950K Total Retail Price of All Prescriptions

Rank: 126 out of 1456

600 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 15,450 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 880 773 1 2
LISINOPRIL 789 699 2 3
LEVOTHYROXINE SODIUM 715 652 3 4
AMLODIPINE BESYLATE 580 552 4 1
METOPROLOL TARTRATE 461 420 5 12
OMEPRAZOLE 447 400 6 5
HYDROCHLOROTHIAZIDE 376 309 7 10
ATORVASTATIN CALCIUM 357 316 8 11
FUROSEMIDE 351 303 9 7
WARFARIN SODIUM 351 332 9 21
GABAPENTIN 282 246 11 13
TRAMADOL HCL 282 262 11 17
ZOLPIDEM TARTRATE 232 183 13 14
METFORMIN HCL 209 184 14 8
METOPROLOL SUCCINATE 206 194 15 19
HYDROCODONE-ACETAMINOPHEN 204 155 S3 16 6
PRAVASTATIN SODIUM 199 173 17 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 160 18 24
CITALOPRAM HBR 187 177 19 22
ALENDRONATE SODIUM 183 178 20 36
ESCITALOPRAM OXALATE 178 162 21 74
SERTRALINE HCL 176 150 22 25
LOSARTAN POTASSIUM 156 151 23 16
KLOR-CON M20 142 135 24 51
FENOFIBRATE 140 119 25 56
FLUTICASONE PROPIONATE 138 113 26 28
CRESTOR 138 118 26 26
NAMENDA 137 137 28 38
ATENOLOL 135 119 29 18
LOSARTAN-HYDROCHLOROTHIAZIDE 127 127 30 41
MELOXICAM 125 99 31 30
ALLOPURINOL 125 116 31 31
SYNTHROID 119 115 33 37
DIOVAN HCT 118 114 34 59
POTASSIUM CHLORIDE 117 101 35 15
GLIPIZIDE ER 114 104 36 86
ADVAIR DISKUS 109 99 37 63
SPIRIVA 108 103 38 75
METFORMIN HCL ER 106 94 39 54
DONEPEZIL HCL 104 104 40 29
CLOPIDOGREL 104 102 40 32
CYCLOBENZAPRINE HCL 104 80 R 40 66
LOVASTATIN 102 98 43 40
ISOSORBIDE MONONITRATE ER 101 96 44 60
DIOVAN 100 92 45 35
KLOR-CON M10 92 92 46 140
NEXIUM 91 79 47 23
PREDNISONE 89 81 48 42
LANTUS 87 79 49 50
PROPRANOLOL HCL 87 71 49 143
HYDRALAZINE HCL 85 57 51 48
CARVEDILOL 85 75 51 20
PANTOPRAZOLE SODIUM 81 53 53 43
CIPROFLOXACIN HCL 78 74 54 58
EVISTA 78 68 54 113
CEFUROXIME 77 69 56 138
CYMBALTA 76 76 57 52
TRILIPIX 75 48 58 188
ZOSTAVAX 75 70 58 187
DIGOXIN 74 70 60 62
NIFEDIPINE ER 73 63 61 81
PROMETHAZINE HCL 73 50 R 61 77
AMLODIPINE BESYLATE-BENAZEPRIL 70 63 63 61
BYSTOLIC 68 68 64 102
JANUVIA 68 64 64 68
RANITIDINE HCL 67 56 66 27
ACTOS 63 57 67 115
LEVOFLOXACIN 62 61 68 79
PLAVIX 62 61 68 46
TAMSULOSIN HCL 62 62 68 34
BENICAR 62 62 68 130
DEXILANT 60 45 72 169
VERAPAMIL ER 60 29 72 82
FINASTERIDE 59 59 74 110
GLYBURIDE-METFORMIN HCL 58 58 R 75 119
EXELON 57 57 76 105
CELEBREX 57 54 76 88
INSULIN SYRINGE 56 37 78 64
NIASPAN 56 50 78 127
BENICAR HCT 55 34 80 160
BENAZEPRIL HCL 54 54 81 57
LABETALOL HCL 53 34 82 180
GLIPIZIDE 53 45 82 53
QUETIAPINE FUMARATE 53 53 82 78
DOXAZOSIN MESYLATE 51 39 85 84
TRICOR 50 46 86 92
NOVOLOG FLEXPEN 50 48 86 198
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.